Central Retinal Vein Occlusion 36-Month Outcomes with Anti-VEGF-Reference-Cited by-同舟云学术

Central Retinal Vein Occlusion 36-Month Outcomes with Anti-VEGF

Published:2023-04 Issue:4 Volume:7 Page:338-345
ISSN:2468-6530
Container-title:Ophthalmology Retina
language:en
Short-container-title:Ophthalmology Retina

Author:

Hunt Adrian^ORCID,Nguyen Vuong,Bhandari Sanjeeb^ORCID,Ponsioen Theodorus^ORCID,McAllister Ian L.,Arnold Jennifer^ORCID,Young Stephanie^ORCID,Gabrielle Pierre-Henry,Mehta Hemal^ORCID,O’ Toole Louise,Alforja Socorro^ORCID,Zarranz-Ventura Javier,Barthelmes Daniel^ORCID,Gillies Mark

Publisher

Elsevier BV

Subject

Ophthalmology

Reference28 articles.

1. Retinal vein occlusions preferred practice pattern;Flaxel;Ophthalmology,2020

2. Guidelines for the management of retinal vein occlusion by the European society of retina specialists (EURETINA);Schmidt-Erfurth;Ophthalmologica,2019

3. Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion;Braithwaite;Cochrane Database Syst Rev,2014

4. Intravitreal aflibercept injection for macular edema resulting from central retinal vein occlusion: one-year results of the phase 3 GALILEO study;Korobelnik;Ophthalmology,2014

5. Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study;Campochiaro;Ophthalmology,2011

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retinal arterial and vein occlusion: is surgery ever indicated?;Current Opinion in Ophthalmology;2024-02-28

2. Proteome Analysis of Bevacizumab Intervention in Experimental Central Retinal Vein Occlusion;Journal of Personalized Medicine;2023-11-07

3. Real-World Management of Macular Edema Secondary to Retinal Vein Occlusion with Intravitreal Aflibercept: 24-month Results from the AURIGA Observational Study;Ophthalmology and Therapy;2023-11-04

4. Outcomes of anti-VEGF treatment for macular edema secondary to central retinal vein occlusion in patients with poor baseline visual acuity;Canadian Journal of Ophthalmology;2023-07